AVE 33.3% 0.2¢ avecho biotechnology limited

funding for phase 3

  1. 25 Posts.
    If the patch is now considerably derisked, why not go to the bank for a $15 million loan rather than creating new shares and lowering share value. I know it might be safer to go to the investors for the money but in the long term, if management are confident of success, we'd have a better price per share if we seek a loan.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.